Morimoto S, Hirano A, Ohkawa T, Doi J, Suzuki A, Hagino K, Kitamura S, Sawada Y, Morita T, Miyazaki Y
Department of Urology, Wakayama Medical College.
Hinyokika Kiyo. 1995 Apr;41(4):245-51.
One hundred and sixty one patients with upper urinary stones were examined for antimicrobial prophylaxis following extracorporeal shock wave lithotripsy (ESWL). They were divided into two groups, the low-risk group (n = 133) and high-risk group (n = 28), according to the risk factors of urinary tract infection. The patients in the low-risk group were further randomized into two groups which were orally given ofloxacin for 7 days after ESWL (Group A, n = 66), no antimicrobial (Group B, n = 67). The patients in the high-risk group were randomly subdivided into three groups which were given flomoxef intravenously for 2 or 3 days and ofloxacin for 4 or 5 days thereafter (Group C, n = 10), flomoxef only for 2 or 3 days and no drugs later (Group D, n = 10), ofloxacin for 7 days (Group E, n = 8). In all of the patients in the low-risk group, during the 7 days after ESWL, fever elevation was observed in only 1.5% of patients, and bacteriuria in 10.0% on the 7th day. There was no difference in frequency of fever elevation and bacteriuria following ESWL between Group A and Group B. These findings indicate that prophylactic antimicrobial after ESWL treatment is not necessary for low risk patients with urinary tract infections. In the high-risk group, the over-all rates of fever elevation and bacteriuria were 21.4% and 24.0% respectively. The difference of effectiveness among the prophylactic regimens of the three groups (Group C, D, E) was not shown.(ABSTRACT TRUNCATED AT 250 WORDS)
对161例上尿路结石患者进行了体外冲击波碎石术(ESWL)后的抗菌预防检查。根据尿路感染的危险因素,将他们分为两组,低风险组(n = 133)和高风险组(n = 28)。低风险组患者进一步随机分为两组,ESWL后口服氧氟沙星7天(A组,n = 66),不使用抗菌药物(B组,n = 67)。高风险组患者随机分为三组,静脉注射氟氧头孢2或3天,之后口服氧氟沙星4或5天(C组,n = 10),仅静脉注射氟氧头孢2或3天,之后不使用药物(D组,n = 10),口服氧氟沙星7天(E组,n = 8)。在所有低风险组患者中,ESWL后7天内,仅1.5%的患者出现发热升高,第7天菌尿发生率为10.0%。A组和B组ESWL后发热升高频率和菌尿发生率无差异。这些结果表明,ESWL治疗后,对于低风险尿路感染患者,预防性使用抗菌药物并非必要。在高风险组中,发热升高和菌尿的总体发生率分别为21.4%和24.0%。三组(C组、D组、E组)预防方案的有效性差异未显示。(摘要截短至250字)